Skip to main content

Table 1 Clinical characteristics and LV function measurements

From: Incremental value of three-dimensional echocardiography for evaluating left atrial function in patients with coronary slow flow phenomenon: a case control study

 Controls (n = 45)CSFP (n = 60)P-value
Clinical characteristics
 Age (yrs)55.53 ± 8.4456.52 ± 8.820.57
 Male sex [n(%)]21 (47%)36 (60%)0.18
 Systolic blood pressure (mm Hg)128.12 ± 14.44125.94 ± 11.420.41
 Diastolic blood pressure (mm Hg)76.71 ± 9.9375.78 ± 9.910.63
 Hypertension [n(%)]20 (44%)26 (43%)0.91
 Diabetes mellitus [n(%)]2 (4%)5 (8%)0.70
 Fasting blood glucose (mmol/L)5.41 ± 0.875.60 ± 0.970.29
 Triglycerides (mmol/L)1.41 ± 0.831.43 ± 0.700.86
 Total cholesterol (mmol/L)4.43 ± 0.804.35 ± 0.850.90
 LDL cholesterol (mmol/L)2.67 ± 0.822.79 ± 0.750.45
 HDL cholesterol (mmol/L)1.16 ± 0.301.07 ± 0.220.10
TFC
 cLAD21.77 ± 3.2342.16 ± 16.11< 0.001
 LCX21.47 ± 3.8535.77 ± 16.53< 0.001
 RCA21.20 ± 4.1136.82 ± 18.76< 0.001
 Mean21.48 ± 2.2738.25 ± 13.57< 0.001
LV systolic function measurements
 LV end-diastolic volume (ml)82.27 ± 15.0885.05 ± 16.920.38
 LV ejection fraction (%)64.27 ± 4.4463.03 ± 3.960.14
 LV GLS (%)−20.58 ± 2.36−19.24 ± 2.270.004
LV diastolic function measurements
 LA Volmax index27.76 ± 7.5131.83 ± 8.470.03
 Mitral E (m/s)74.89 ± 15.4766.67 ± 17.240.01
 Mitral E/A1.16 ± 0.370.96 ± 0.290.003
 Mitral e’ (cm/s)8.67 ± 2.197.72 ± 1.690.01
 Mitral E/e’8.99 ± 2.268.86 ± 2.450.78
 Tricuspid regurgitation velocity (m/s)2.01 ± 0.782.23 ± 0.890.56
  1. Values shown are means±SD or percentages
  2. Abbreviation: LDL low-density lipoprotein, HDL high-density lipoprotein, TFC thrombolysis in myocardial infarction frame count, cLAD corrected left anterior descending coronary artery, LCX left circumflex coronary artery, RCA right coronary artery, LV left ventricle, GLS global longitudinal strain, LA Volmax maximal LA volume, E early diastolic flow velocity, A late diastolic flow velocity, e’ early diastolic annular velocity